Skip to content
Screener

Aurinia Pharmaceuticals AUPH Finance Lease Interest

Finance Lease Interest at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.43M-77.4%
RB Global logo
RB GlobalRBA
$1.4M+75.0%
Xylem logo
XylemXYL
$1.5M+50.0%
Insmed logo
InsmedINSM
$464K-11.5%
Kimberly-Clark logo
Kimberly-ClarkKMB
$750K0.0%
Vulcan Materials Company logo
Vulcan Materials CompanyVMC
$100K-50.0%

Segments

By geography

See full
Visp, Switzerland$900K-18.2%

Other financials

Income statement

See full
Revenue$83.2M+18.9%
Gross profit$76.7M+21.9%
Operating income$46.3M+131%
Net income$37.4M+73.9%
EPS (diluted)$0.28+75.0%

Balance sheet

See full
Cash & equivalents$179.8M+239%
Total debt$80.6M-17.7%
Total equity$614.9M+83.4%
Total assets$792.3M+57.6%

Cash flow

See full
Operating cash flow$52.6M+18.8%

Valuation

See full
Market cap$2.07B+35.7%
Enterprise value$1.98B+25.5%
P/E6.6×-18.6×
P/S6.7×+0.8×

Profitability

See full
Gross margin90.4%+0.8pp
Operating margin48.4%+28.4pp
Net margin100.8%+77.5pp

Returns & leverage

See full
Return on equity66.1%+48.8pp
Debt / equity0.1×-0.2×
Current ratio5.4×+0.2×